COMMUNIQUÉS West-GlobeNewswire

-
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/03/2019 -
Evolve Treatment Centers for Teens Opens New Santa Barbara Location
06/03/2019 -
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
06/03/2019 -
Alamance-Caswell & Greensboro Hospice Organizations Announce Intent-to-Merge Plans to Better Meet End-Of-Life Care Needs for Patients and Families
06/03/2019 -
North Bud Farms Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor
06/03/2019 -
Driven Deliveries, Inc. Announces Addition of Former CEO of Osmio (Now GrubHub), Adam Berk, to its Board of Directors
06/03/2019 -
Nicox : Document de référence 2018
06/03/2019 -
Trident Brands Subsidiary Brain Armor® Announces Nationwide Distribution With CVS Pharmacy
06/03/2019 -
Healthagen to Study Real-World Application of Welldoc’s OneTouch Reveal® Plus Among Type 2 Diabetes Patients
06/03/2019 -
Innovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in Boston
06/03/2019 -
Tauriga Sciences Inc. Cancels its Previously Planned Corporate Action to Increase its Authorized Shares
06/03/2019 -
DLT Resolution Provides Critical Voice and Data Services to World Wide Logistics Services
06/03/2019 -
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 14th at 4:30 p.m. Eastern Time
06/03/2019 -
Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019
06/03/2019 -
Homology Medicines to Present at Cowen Healthcare Conference
06/03/2019 -
PSIQ Files Amendment # 1 to Form S-1 as the Next Step to Becoming an SEC Reporting Issuer and Uplisting to OTCQB
06/03/2019 -
Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication
06/03/2019 -
Exactus Places $1 Million Purchase Order for CBD Products to Accelerate Near Term Growth
06/03/2019 -
Hemispherx Biopharma Announces $5.3 Million in Expected Gross Proceeds from Recently Expired Rights Offering
06/03/2019
Pages